The molecular events associated with acute and chronic exposure of mesangial cells (MC) to hyperglycemia were evaluated. We found that, unlike high glucose (HG) and Amadori adducts, advanced glycation end products (AGE) and transforming growth factor-β (TGF-β) induced p21
related to the release of transforming growth factor-β (TGF-β) in response to the excess of glucose (5) . However, the failure of the anti-TGF-β antibody to completely abrogate kidney hypertrophy in diabetic mice (6) suggests that, besides TGF-β, other mediators such as IGF-1 and connective tissue growth factor (CTGF) may play a role in glucose-induced kidney disease (7) (8) (9) . Beside the effects exerted by high glucose (HG) or Amadori adducts (10, 11) , several lines of evidence indicate an emerging role of the advanced glycation end products (AGE) in the pathogenesis of both micro-and macrovascular complications (12) . Indeed, kidney hypertrophy, mesangial expansion, and diabetic nephropathy-like lesions have been induced in a rat model by advanced glycation end products (13) and in transgenic mice expressing the receptor for AGEs (RAGE; ref 14) . RAGE is the best characterized cell surface molecule to which AGE bind (12) . Recent data obtained in homozygous RAGE null mice support a key role of RAGE in mediating AGE-induced vascular dysfunction (15) . Moreover, the renoprotective effect (exerted by) of inhibitors of AGE formation on experimental diabetic nephropathy suggests a crucial role of these biological compounds also in this pathological setting (7) .
Cell hypertrophy can be controlled by cell-cycle dependent or independent mechanisms (16, 17). Cell-cycle independent hypertrophy mainly depends on accumulation of the overall protein content in the cells. By contrast, cell-cycle dependent hypertrophy is due to the increased synthesis of structural proteins that occurs during G 1 in the absence of DNA synthesis and cell division (17). G 1 growth arrest is regulated by many elements of the cell cycle machinery (18). Among these elements, G 1 cyclin-CDK complexes play an important role by phosphorylating, and thus inactivating, the retinoblastoma subsceptibility gene (Rb; ref 19 ). Moreover, regulation of cell-cycle progression also depends on the inhibitory effect exerted on the CDK-associated kinase activity by the cyclin-kinase inhibitors (CKI) that include p21 CIP1/WAF1 (p21 waf ) and p27 KIP1 (18, 20) . Several lines of evidence sustain the notion that regulators of cell proliferation, by affecting the expression of CKI, modulate cyclin-CDK kinase activity (20, 21) . In particular, a potential role of p21 waf in mediating TGF-β-induced cytoinhibitory effect has been documented via a p53 independent pathway (21). It has been reported that p21
waf expression can also depend on the transcriptional activity of the signal transduction and activator of transcription (STAT) 5 (22-24) . STAT5 belongs to the family of signaling proteins regulating different biological responses. Upon cytokine or growth factor stimulation STAT proteins undergo tyrosine phosphorylation, translocate into the nucleus, and activate transcription of target genes mainly involved in regulation of cell proliferation (25) . At this regard, it has been reported that STAT5 transcriptionally regulates the expression of cyclin D 1 in rat kidney fibroblasts treated with AGE (26) . Moreover, recent data demonstrate that STAT1 activation is involved in HG-induced increase of TGF-β and fibronectin synthesis in MC (11) and that the effect of angiotensinmediated JAK2/STAT pathway is altered by HG (27) , suggesting a role of the STAT signaling pathway in regulating the biological response of MC to either acute or chronic glucose insult.
We focused our study on the molecular events associated with acute and chronic exposure of MC to hyperglycemia or to TGF-β and in particular on the molecular mechanisms involved in the regulation of MC growth. Our results demonstrate that AGE and TGF-β, but not HG and Amadori adducts, converge their signals on p21 waf to regulate the progression through the cell cycle via STAT5 activation. Moreover, the observation that the expression of the activated STAT5 and of p21 waf increased from early to advanced stage of nephropathy suggests a potential role of these molecular mechanisms also in vivo.
RESEARCH DESIGN AND METHODS

Reagents
RPMI medium, bovine serum albumin (BSA), glycated human albumin, human albumin, Dglucose, D-mannitol, Sepharose-protein A, FITC-conjugated, and RITC-conjugated anti-rabbit IgG or anti-mouse IgG were all from Sigma (St. Louis, MO). Bovine calf serum BCS (endotoxin-tested) was obtained from HyClone (Logan, UT). Trypsin was purchased from Difco (Detroit, MI). hTGF-β1 was from Chemicon International Inc. (Temecula, CA). Nitrocellulose filters, HRP-conjugated anti-rabbit IgG and anti-mouse IgG, molecular weight markers, chemiluminescence reagent (ECL), 32 P-ATP, and poly(dIdC) were from Amersham (Braunschweig, Germany). Physiochemical properties of glycated human albumin from Sigma are the following: fluorescent AGE: undetectable; carboxymethyllysine (CML)/mg protein: 170 ng; Lys modification (%): 91.9 ± 5.2; Arg modification (%): 98.6 ± 0.5; IGF-1: undetectable; LPS: undetectable (28) .
Antisera
Anti-phospho-STAT5 was from New England BioLabs (Beverly, MA). Anti-STAT5, anti-RAGE, anti-TGF-βRII, anti-CD31, anti-cyclin D1, anti-βactin, and anti-p21 waf antibodies were from Santa Cruz Biotechnology (Heidelberg, Germany). Anti-hTGF-β 1 neutralizing antibody was purchased from Chemicon International Inc. Anti-nephrin antiserum was kindly provided by Dr. G. Camussi.
Patients and controls
Renal biopsies were obtained from 12 diabetic patients: 4 with microalbuminuria, 3 with nonnephrotic proteinuria (ranging from 1 to 3 g/24 h), and 5 with nephrotic syndrome (ranging from 3.5 to 5 g/24 h).
As control, 10 specimens were obtained from normal kidney portions of patients without proteinuria who underwent surgery for cancer.
The study was approved by the Ethical Committee and informed consent was obtained from all subjects. The procedures were in accordance with the Helsinki declaration. Only specimens from diabetic patients with classic histological features of diabetic nephropathy were selected, whereas those with other pattern of injury were excluded. Microalbuminuria was defined as a urinary albumin excretion of 30-300 mg/24 h and macroalbuminuria as more than 300 mg/24 h.
In vitro glycation: Amadori adducts (glycated proteins), CML, and AGE
Amadori adducts was prepared from human albumin that was purified by chromatography on Affi-gel Blue and DEAE-Sepharose and incubated for 5 days at 25°C in buffer saline containing 500 mg/dl (27.8 mM) glucose. After dialysis to remove free glucose the glycated species were separated from non glycated albumin by affinity chromatography on phenylboronate agarose (PBA). The PBA pass through, used as source material for nonglycated albumin contained <0.05 mol glucose/mol albumine (compared with 1 mol gulose/mol albumin of glycated albumine (29) (30) (31) . Characterization of purified glycated and not glycated proteins was performed as described by Cohen et al. (29) . AGE were obtained by incubation of human albumin with 0.3 mmol/l ΕDΤΑ (pH 7.4) at 37°C for 8 wk in the presence or in the absence of freshly prepared 25 mmol/l glucose. After dialysis to remove free glucose affinity chromatography on phenylboronate agarose (PBA) was used to separate AGE from non glycated albumin. Carboxymethyllysine (CML)-BSA was prepared by incubating 50 mg/ml of BSA at 37àC for 24 h with 45 mM glyoxylic acid and 150 mmol sodium cyanoborohydride (NaCNBH3) in 2 ml of 0.2 M phosphate buffer (pH 7.4), followed by PD-10 column chromatography and dyalisis against PBS (32) . To confirm the presence of AGE or CML-BSA the blocking anti-RAGE antibody was used (32) . Parallel experiments were performed by using Amadori adducts and 25 mmol glucose. Endotoxin contamination in our preparations was tested by the Limulus amebocyte assay, and the concentration was <0.1 ng/ml.
Culture media were also added with normal glucose concentration (5.5 mmol/l; NG) or high glucose concentration (25 mmol/l; HG) or normal glucose plus mannitol (19 mmol/l; HM).
Cell culture and transfection
MC were cultured and characterized as described previously (33) . Wild-type and p21−/− fibroblasts were cultured as described previously (34) . MC were transfected with the empty vector, with the dominant-negative STAT5 (∆STAT5) by the lipofectin method, and the expression was assayed by EMSA. The constitutive active STAT5 (1*6 STAT5) construct (35) was cloned in pEGFP-C1 and transiently transfected in MC by the lipofectin method. The empty vector was used as negative control. The transfection efficiency was evaluated by immunofluorescence, and the percentage of transfected cells was from 70 to 80%.
Immunoprecipitation and Western blot analysis
MC monolayers were serum-starved for 24 h at 37°C and unstimulated or stimulated with different stimuli in the presence or in the absence of the blocking anti-TGF-β or the anti-RAGE antibody. MC were lysed in cold DIM buffer (50 mmol/l PIPES, pH 6.8, 100 mmol/l NaCl, 5 mmol/l MgCl 2 , 300 mmol/l sucrose, 5 mmmol/l EGTA, 2 mmol/l sodium ortovanadate plus 1% Triton X-100, and a mixture of protease inhibitors/ 1 mmol/l phenylmethylsulfonyl fluoride, 10 mg/ml leupeptin, 0.15 units/ml aprotinin, 1 mg/ml pepstatin A). Equal amount of proteins (500 µg) were immunoprecipitated with the anti-STAT5 antibody and the immunocomplexes were bound to protein A-Sepharose beads. Bound proteins were eluted and processed as described previously (36, 37) . For Western blot analysis after lysis, protein concentration was obtained as described previously (36, 37) .
Preparation of nuclear extracts and gel retardation assay (EMSA)
Nuclear extracts from untreated and from AGE-or TGF-β-treated MC were prepared as described by Sadowski and Gilman (38) . The oligonucleotides used correspond to the p21SIE sequence (22). Gel retardation reactions were performed as described previously (36) .
Flow cytometry
MC (wild type), MC transfected with the empty vector or with the modified STAT5 constructs (1*6 STAT5 or ∆STAT5), and wild-type or p21−/− fibroblasts were stimulated for 18 h in serum-free medium with albumin (0.6 mg/ml), AGE (0.6 mg/ml), TGF-β (10 ng/ml), HG (25 mM glucose), Amadori adducts (0.6 mg/ml), and with 10% FCS as positive control for cell proliferation, and then fixed with 70% ethanol. After digestion with RNase, DNA was stained with propidium iodide and analyzed with a flow cytometer. (FACScan, Becton-Dickinson Immunocytometry Systems, San Jose, CA). In some experiments neutralizing anti-TGF-β or anti-RAGE antibodies were used. Percentage of cells in each phase of cell cycle was determined by ModFit LT Software (Verity Software House Inc., Topsham, MA).
Collagen assay
Collagen assay was performed using the Sircol collagen assay method (Accurate Chemical and Scientific Corp., Westbury, NY). Briefly, 1,000 µl of Sircol dye reagent was added to 100 µl of test samples or collagen standards and incubated at 25°C for 30 min. After centrifugation at 5,000 g for 5 min, the supernatants were drained off and discarded. One thousand microliters of 0.5 N NaOH was added to the collagen-bound dye pellet to release the bound dye into solution. The OD of each sample was determined with a microplate reader (Dynatech Laboratories) at 540 nm.
Immunofluorescence microscopy
Kidney biopsies from healthy subjects and from micro-and macroalbuminuric diabetic patients were fixed and embedded in paraffin and processed as described (24) . Sections were stained with ethidium bromide (for nuclear staining), with the anti-phospho-STAT5 and the anti-p21 waf antibodies. Indirect immunofluorescence analysis was performed as described previously (24) . The primary antibody was omitted on section used as negative control. Histopathologic slides were examined blindly by three independent observers. All cells inside glomeruli with nuclear staining of any intensity were defined as positive. Three to four glomeruli per section and four consecutive sections per case were examined. Positive immunostaining was expressed as the percentage of p-STAT5-and p21 waf -stained nuclei per total nuclei in the sample.
Statistical analysis
All in vitro results are representative of at least three independent experiments performed in triplicate. Densitometric analysis using a Bio-Rad GS 250 molecular imager was used to calculate differences in the fold induction of protein activation or expression (STAT5 activation or p21 waf and cyclin D1 expression; *P<0.05, statistically significant between experimental and control values: §P<0.05, statistically significant between experimental values in the presence of blocking antibodies). Differences in the amount of positive immunostained nuclei between samples from micro-and macroalbumiuric patients were considered statistically significant at P < 0.05. Significance of differences between experimental and control values was calculated using ANOVA with Newman-Keuls multicomparison test.
RESULTS
AGE and TGF-β increase p21
waf expression and regulate cell-cycle progression in MC Different growth factors including IGF-1 and CTGF, either in the presence or in the absence of ΤGFβ, have been shown to be involved in glucose-induced MC hypertrophy (9) . Moreover, AGE formation, as the result of prolonged hyperglycemia, has been also reported to control MC growth, (7, 8) . However, it is not clear whether the effects of AGE are direct or mediated by the release of soluble factors. (39, 40) . To clarify the molecular mechanisms involved in the control of MC growth we evaluated the effects exerted by different stimuli on the regulation of cellcycle machinery. First, we analyzed (Fig. 1A) the expression of the receptor for AGE (RAGE) and the type II TGF-β receptor in MC. We then evaluated the effects of the indicated stimuli on the expression of proteins that control cell-cycle progression: p21 waf and cyclin D1. As shown in Fig. 1B , unlike HG and Amadori adducts, TGF-β, AGE, and the other RAGE-interacting molecule, CML, led to an increased expression of p21
waf that picked at 18 h (data not shown). Albumin, normal glucose (NG), and mannitol treatment (HM) used as control did not affect p21 waf expression. To confirm that the effect induced by AGE and CML was specifically mediated by RAGE engagement, MC were also pretreated with the blocking anti-RAGE antibody. The results reported in Fig. 1C demonstrate that, in this experimental condition, AGEor CML-induced p21 waf expression was completely abrogated. A recent report showed that HGinduced renal hypertrophy (41) is associated with the increased expression of cyclin D1 (41) . The results reported in Fig. 1D demonstrated that AGE and TGF-β, unlike HG and Amadori adducts, did not induce the expression of cyclin D1. Moreover we showed that the effect on cyclin D1 exerted by HG and Amadori adducts was not affected by pretreatment with the blocking anti-RAGE antibody, suggesting that HG or Amadori adducts and AGE could elicit discrete downstream signals by engaging different receptors.
It has been reported that commercial glycated human albumin does not contain AGE but only CML (28) . We then compared the effects of commercial albumin with AGE and CML preparations. Similar results were obtained when these preparations were used alone or in combination with the anti-RAGE antibody (data not shown).
Since similar results were obtained by commercial glycated human albumin, AGE, and CML all the experiments were performed with AGE.
To analyze the relationship between p21
waf expression and changes in cell-cycle events, MC DNA content was evaluated by flow cytometry after treatment with AGE, TGF-β, Amadori adducts, and HG,. The results reported in Table 1 demonstrated that the cell population in the S and G 2 /M phases decreased after treatment of the cells with both AGE and TGF-β. Indeed, the percentage of the cells in the S phase were reduced to 19 and 21% of the total compared with the control value (28%) and albumin (30%) in response to AGE and TGF-β treatment, respectively. Consistent with the inability of HG and Amadori adducts to affect the expression of p21 waf the percentage of the cells in the S phase was comparable to the control value (28 and 29%, respectively). This effect induced either by AGE and TGF-β was associated with an increase (65 and 62%, respectively) in the percentage of cells in G 0 /G 1 . Moreover, while the addition of the neutralizing anti-TGF-β antibody completely prevented the effect of TGF-β, it only partially reverted the effect of AGE (G 0 /G 1 52 and 59% respectively). Finally, as shown by the pretreatment with the blocking anti-RAGE antibody, the effect exerted by AGE is mediated by RAGE engagement. These data indicate that TGF-β and AGE, possibly by converging their signals on p21 waf expression, can independently regulate the progression of MC into the cell cycle.
AGE, independently of TGF-β, triggers STAT5 activation and p21
waf expression in MC It has been reported that p21 waf can regulate the TGF-β-mediated cytoinhibitory effect by a p53 independent mechanism (21, 42) We previously reported that in endothelial cells the intracellular level of p21
waf is under the control of the STAT5 transcriptional activity (24) . The observation that AGE and TGF-β increased the level of p21 waf in MC prompted us to evaluate their effects on STAT5 activation. As shown in Fig. 2 , AGE and TGF-β triggered STAT5 activation. However, as shown by the kinetic analysis, while AGE-induced STAT5 activation was rapid and transient, the effect induced by TGF-β was more persistent (Fig. 2A) . Moreover, AGE-but not TGF-β-mediated STAT5 activation was completely abolished by the addition of the blocking anti-RAGE antibody (Fig. 2C) . It has been reported that long-term high glucose treatment led to a constitutive activation of the JAK2/STAT pathway (27) . Consistently, we found a constitutive STAT5 activation after 48 h of HG treatment (Fig. 2E) . However, when we performed the experiments in the same experimental conditions used for AGE and TGF-β, we failed to detect STAT5 activation, suggesting that second messengers are involved in long-term HG-mediated STAT5 activation. Moreover, no effect on STAT5 activation was detected either after short-or long-term treatment with Amadori adducts (data not shown) or mannitol. To assess whether AGE-and TGF-β-mediated STAT5 activation could regulate p21 waf expression, EMSA analysis was performed using a p21SIE2 sequence that recognizes STAT binding site in the p21 waf promoter sequence (22). Consistent with the role of STAT5 in regulating gene transcription, nuclear extracts from stimulated MC were able to form a p21SIE2 complex that was displaced by the unlabeled sequence. The presence of STAT5 in the DNA-protein complex was demonstrated by the ability of the anti-STAT5 antibody to supershift the p21SIE2 binding complex (Fig. 2B ).
The observations that the anti-TGF-β antibody only partially abrogated AGE-induced G 1 arrest and that both ligands were able to induce STAT5 activation and p21 waf expression led us to hypothesize that these events, possibly involved in the control of MC growth, could be exerted by AGE, independently on TGF-β. To validate this possibility experiments were performed in the presence of the anti-TGF-β blocking antibody. As shown in Fig. 2 , the anti-TGF-β antibody was able to affect TGF-β-, but not AGE-induced STAT5 activation (Fig. 2C) . Moreover, when the effect of the anti-TGF-β antibody was evaluated on p21 waf expression (Fig. 2D) , we found that, although it completely abrogated the effect of TGF-β, it only partially reduced that of AGE.
We further analyzed the effect of different stimuli on collagen production. Consistently with previous reports (40) we found that AGE-mediated collagen production was strictly controlled by the release of TGF-β (Fig. 2F) . On the contrary, consistent with previous report (9) the effect of HG-and Amadori adducts-induced collagen production was only partially controlled by TGF-β. Moreover, the observation that the blocking anti-RAGE antibody only affected AGE-mediated effect, straitened the involvement of different receptors to elicit this biological response (Fig.  2F) . No effects were observed when mannitol or NG was used as control.
p21
waf expression in MC expressing the inactive (∆STAT5) or the constitutive active (1*6 STAT5) STAT5 protein
To validate the role of STAT5 in regulating p21 waf expression, MC were transfected with an inactive form of STAT5 (∆STAT5). As reported in Fig. 3 , MC expressing the empty vector still retained the ability to increase p21 waf expression in response to AGE or TGF-β. By contrast, when both stimuli were used to treat MC expressing the ∆STAT5 construct, no increase in p21 waf expression could be detected. No changes in p21 waf expression were observed in cells stimulated with albumin, HG, or Amadori adducts.
The expression of p21 waf in response to AGE or TGF-β was also evaluated in MC transiently transfected with an activated form of STAT5 (1*6 STAT5). The results, reported in Fig. 3 , demonstrated that, in the presence of the constitutive activated STAT5 protein, p21
waf was highly expressed and either AGE or TGF-β could not further increase its level. Similarly, no changes in p21 waf expression were found in response to HG or Amadori adducts.
AGE and TGF-β-mediated G 1 arrest, but not collagen production, depends on STAT5 activation
The involvement of the STAT5-mediated p21 waf expression in AGE-and TGF-β-induced cellcycle events was further evaluated by flow cytometry in MC expressing the 1*6 STAT5 and the ∆STAT5 constructs. The experiments reported in Table 2 demonstrated that in MC expressing the empty vectors both stimuli were able to increase the percentage of cells in G 0 /G 1 . On the contrary, as much as 60% of MC that constitutively expressed the activated STAT5 protein and high level of p21 waf were in G 0 /G 1 ; this percentage could not be further increased by AGE, TGF-β, or serum. The consistence of our experiments was strengthened by the observation that AGE and TGF-β treatment led to a reduction in the percentage of cells in G 0 /G 1 and to a corresponding increase in the percentage of cells in the S phase (~50%) in MC expressing the ∆STAT5 construct (Table 2) . Moreover, consistent with the inability of HG and Amadori adducts to induce p21 waf expression, no changes in the percentage of cells in the cell cycle phase were detected in both transfectants.
MC expressing either the inactive or the constitutive active STAT5 mutants, stimulated with AGE, TGF-β, NG, HG, and Amadori adducts were also evaluated for collagen production. The results depicted in Fig. 4 show that, except NG, all stimuli induced collagen production in the transfectant. This observation confirmed the specific role of STAT5 in the regulation of cellcycle progression elicited by AGE and TGF-β.
AGE and TGF-β fail to induce growth arrest in p21−/− fibroblasts
The potential role of p21 waf in mediating the TGF-β growth arrest has been previously suggested by Li et al. (42) . To further confirm the involvement of p21 waf in AGE and TGF-β-induced MC growth arrest, wild-type and p21−/− fibroblasts were treated with AGE, TGF-β, HG, and Amadori adducts and assayed for their ability to progress into the cell cycle, as well as to produce collagen. As shown in Fig. 5A , we found that p21−/− fibroblasts failed to undergo growth arrest in response to18 h treatment with different stimuli and that they still retained the ability to produce collagen (Fig. 5B) . Similar results were obtained when the cells were stimulated for 48 and 72 h (data not shown).
STAT5 is activated and p21
waf is expressed in diabetic kidney biopsies
The expression of the activated STAT5 and of p21 waf was evaluated on kidney biopsies from nondiabetic or diabetic subjects (Table 3 ) by immunofluorescence microscopy. As shown in Fig.  6 , A-C, the expression of the activated STAT5 and of p21 waf could not be detected in kidney biopsies from nondiabetic subjects. By contrast, the activated STAT5 and p21
waf were coexpressed by a lower number of cells in kidney sections from microalbuminuric patients than in those from macroalbuminuric patients (15% ± 3 vs. 45% ± 4 of the total nuclei, P<0.05). To confirm the nuclear localization of the activated STAT5 and p21 waf , sections were subsequently stained with ethidium bromide. As shown in Fig. 6F and I, nuclei of positive pospho-STAT5 immunostained cells became yellow. Parallel experiments were performed with a FITC-labeled p21 waf , and similar results were obtained (data not shown) The topographic localization of the positive cells in the glomeruli and the negative immunostaining for nephrin and CD31 (data not shown) suggest their mesangial nature. As negative control, nonimmune mouse or rabbit IgG was used in place of primary antibodies (data not shown).
DISCUSSION
The results of the present study demonstrate that unlike HG and Amadori adducts, AGE and TGF-β regulate MC cell-cycle progression by increasing the expression of the cell-cycle related protein p21
waf and that these effects, unlike collagen production, are mediated by the transcriptional activity of STAT5. It has been reported that STAT proteins mediate TGF-β stimulation and fibronectin production induced by HG (27) . In particular Wang et al. (11) demonstrated that STAT1, but not STAT3 or STAT5, was involved in HG-mediated biological response. Exposure of proteins to reducing sugars like glucose results in nonenzymatic glycation that forms reversible Shift bases and Amadori compounds. A series of further complex molecular rearrangements yields irreversible AGE that accumulate in various tissues (8, 12) . Thus, besides the direct and acute tissue damage exerted by hyperglycemia, several tissue dysfunction are induced by AGE in diabetic patients (12) . Several data support the notion that AGE-mediated effects mainly depend on their ability to induce the release of several soluble mediators that include also TGF-β (7−10). We showed that MC expresses both the receptor for AGE and for TGF-β, which are known to act in autocrine or paracrine fashion to elicit profound effects on cell growth (5, 12, 40, 43) .
Diabetic nephropathy is predominantly characterized by hypertrophy rather than by hyperplasia, of MC (44) . MC hypertrophy seems to be under the control of events regulating cell cycle progression (4) . The prevention of cyclin-mediated phosphorylation of Rb by TGF-β has been implicated as an important impediment to cell-cycle progression through the late G 1 (45) . Among regulators of G 1 progression, the cyclin inhibitors p27 kip and p21 waf have been recognized as main regulators of TGF-β-induced cell-cycle arrest (21, 46). Moreover, it has been also recently shown that HG, by increasing the expression of cyclin D1, can induce MC hypertrophy (41) .
Consistently, we demonstrated that HG and Amadori adducts induce the expression of cyclin D1 without affecting the expression of p21 waf and its associated cell-cycle events. Conversely, TGF-β or AGE treatment led to an increased expression of p21 waf and inhibition of the progression through the cell cycle. These findings suggest that different intracellular signaling mechanisms regulate HG-or AGE-and TGF-β-induced biological response and that acute hyperglycemia per se could affect MC hypertrophy independently of TGF-β.
Circulating AGE has analogous influences as TGF-β on MC biology. Indeed, AGE increases matrix production and decreases MC proliferative capacity by inducing a coordinated increase in the expression of both TGF-β and type II TGF-β receptor (47). It has been reported that neutralizing anti-TGF-β antibodies prevented collagen biosynthesis by high glucose in culture (5, 48) and that chronic administration of monoclonal anti-TGF-β antibody inhibited matrix expansion in db/db mice but do not completely reverse renal damage (49). Consistent with these data, our results demonstrated that in cultured MC neutralization of TGF-β activity completely abrogated the effect of AGE-and TGF-β-mediated collagen production. However, although the neutralizing anti-TGF-β antibody prevented the effect of TGF-β on the expression of p21
waf and the related cell-cycle events, it did not completely inhibit these effects induced by AGE. Therefore, our results first demonstrated that AGE can affect cell-cycle progression independently of TGF-β (see the model reported in Fig. 7 ) and suggest a molecular mechanism responsible for the limited therapeutic effect of the anti-TGF-β antibody in vivo.
It is well established that HG and Amadori adducts affect collagen production directly or by means of the release of soluble mediators, such as IGF-1, CTGF, and TGF-β (7-10). In agreement with these observations we found that, as AGE and TGF-β, also HG and Amadori adducts induced the production of collagen. Moreover, the blocking anti-RAGE antibody was able to completely abrogate collagen production induced by AGE but not by HG and Amadori adducts. This observation rises the possibility that both acute and prolonged hyperglycemia can contribute to extracellular matrix production and promote the development and/or the progression of renal damage through the engagement of different receptors.
The p53 status, by regulating p21 waf transcription, seems to represent the main modulator of G 1 arrest in response to inhibitory factors (21). However, TGF-β-induced G 1 arrest occurred also in cells depleted of p53 so that transcriptional factors, other than p53, have been suggested to regulate its cytoinhibitory effect (42) . The transcriptional factor STAT5 has been shown to regulate the expression of p21 waf during megakaryocyte differentiation and in endothelial cells treated with AGE (24, 25) . Herein we show that in MC the DNA binding activity of STAT5 is required for AGE-and TGF-β-mediated p21 waf expression and G 1 arrest, but not for collagen production. Thus our results identify STAT5 as an alternative transcriptional factor specifically involved in the control of p21 waf expression in this pathological setting.
The activation of STAT5 in response to long term stimulation with HG has been reported (11, 27) , but no data are available on the early effect of HG on this signaling pathway. Here we found that, unlike long-term, short-term HG stimulation did not led to STAT5 tyrosine phosphorylation. It is possible that soluble mediators released in response to HG directly contribute to the constitutive activation of STAT5. Alternatively, in accordance with Amiri et al. (27) , it can also be speculated that second messengers released in response to HG (by decreasing the functional activity of the phosphatase SHP-1) may constitutively activate JAK2 and its downstream target STAT5. Nevertheless, our data indicate that STAT5 cannot be directly activated by HG and that the STAT5 signaling pathway does not participate to the signaling events regulating extracellular matrix production.
The type I and type II TGF-β receptors are unique in that each has a short cystein-rich extracellular domain, a single transmembrane segment, and a long cytoplasmic region with a serine/threonine kinase domain (40) . The first step in signaling is the interaction of the ligand with the type II receptor forming a heterodimeric complex. Phosphorylation of the type I receptor by the type II receptor is an essential event of TGF signaling (40) . As the result of receptor phosphorylation, the transcriptional factors Smads 2 and 3 become activated and Smad 3, accumulated in the nucleus, exerts its transcriptional activity on the TGF-β responsive genes (40) . Data presented herein provide the first evidence that TGF-β, besides activating the transcriptional activity of Smads, can also regulate the expression of its target genes by a STAT5-mediated pathway.
Experimental diabetic nephropathy is associated with glomerular hypertrophy in normal mice but not in p21 waf null mice (50). Our findings that both AGE and TGF-β failed to induce growth arrest on p21 waf null fibroblasts clearly demonstrated the crucial role of the CKI p21 waf in mediating the cytoinhibitory effect exerted by both ligands and sustain the possibility that the expression of p21 waf in response to AGE and TGF-β could not only regulate G 1 arrest but also contribute to renal hypertrophy.
Reduction or neutralization of glycated albumin in the db/db mouse model of type II diabetes ameliorates mesangial expansion, overexpression of matrix proteins, and renal insufficiency (49). In human type I diabetes the plasma glycated albumin concentration is independently associated with the presence of nephropathy (10) . These findings indicate that diabetic milieu and in particular glycated proteins, via the release of TGF-β, play a central role in the onset and progression of diabetic nephropathy. Our data identify a novel signaling pathway activated independently by TGF-β and AGE that, by converging on p21 waf expression and by regulating cell-cycle events, can contribute to the progression of diabetic nephropathy (see the model in Fig.  7 ). The potential in vivo role of these molecular mechanisms is sustained by the immunofluorescence analysis on kidney biopsies showing a positive immunostaining for both the activated STAT5 and p21 waf in MC and an increase of their expression from early to advanced diabetic nephropathy.
Adherence to the therapeutic recommendations, such as glycemic and blood pressure control, significantly decreased diabetes-associated microvascular complications. However, conventional therapies and experimental usage of anti-TGF-β antibody did not totally halt the progression of diabetic nephropathy. AGE are senescent proteins that accumulate during prolonged exposure to hyperglycemia and can also engage cell surface receptors even after long period of good glycemic control. Therefore, our results sustain the possibility that RAGE engagement by AGE could represent the TGF-β independent mechanism that contributes to the maintenance or progression of diabetic nephropathy in susceptible subjects. Moreover, the demonstration that the STAT5 signaling pathway is involved in this pathological setting may provide a rational for novel therapeutic strategies that combining anti-TGF-β antibodies and specific inhibitors of the STAT pathway might control the progression of diabetic nephropathy. G0/G1  52±6  50±3  65±8  56±5  55±3  62±4  52±4  51±3  51±2  42±4  S  28±3  30±4  19±4  22±3  25±2  21±3  27±4  28±4  29±3  36±3  G2/M  20±4  20±3  16±3  22±3  20±3  17±2  21±3  21±3  20±2  22±4 Unstimulated MC (control) or MC stimulated for 18 h with albumin, AGE (0.6 mg/ml), alone or in combination with neutralizing anti-TGFβ antibody (20 ng/ml) or with the blocking anti-RAGE antibody (20 µg/ml), TGFβ, alone or in combination with the neutralizing anti-TGFβ antibody, HG (25mM of glucose), Amadori adducts (0.6 mg/ml) or cultured in presence of 10% FCS (positive control) were washed and fixed with ethanol and processed as described in Methods. Similar results were obtained in 3 different experiments. G0/G1  51±5  45±4  47±3  50±2  52±4  44±3  S  38±4  50±5  49±4  36±3  37±3  43±4  G2/M  10±2  5±1  4±1  14±3  11±4  13±3 MC expressing the empty vector, 1*6 STAT5 and ∆STAT5 constructs were untreated (control) or treated with AGE, TGFβ, HG, Amadori adducts or cultured in presence of 10% FCS (positive control). After stimulation, MC were fixed with ethanol and processed as described in Methods. Similar results were obtained in 3 different experiments. waf expression. B) MC unstimulated or stimulated with indicated stimuli for 18 h were lysed. Cell extracts were subjected to 15% SDS-PAGE. Proteins were electrophoretically transferred to nitrocellulose filters and probed (IB) with an anti-p21 waf antibody. C) Effect of blocking anti-RAGE antibody on p21 waf expression. MC treated with indicated stimuli, alone or in combination with blocking anti-RAGE antibody, were lysed and processed as above. Filter was IB with an anti-p21 waf antibody. D) Expression of cyclin D1. MC treated as indicated, alone or in combination with the blocking anti-RAGE antibody, were lysed and processed as above. Filter was probed (IB) with an anti-cyclin D1 antibody. β actin IB was used to show amount of loaded proteins. p21
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waf and cyclin D1 expression were also quantified by densitometric analysis, as described in Methods. NG, normal glucose; Alb, albumin; HG, high glucose; Am, Amadori adducts; HM, mannitol. waf expression and collagen production. A) Kinetic of STAT5 activation in response to TGFβ and AGE. MC were stimulated with TGFβ or AGE for different time intervals. Cells extracts were IP with an anti-STAT5 antibody and subjected to 8% SDS-PAGE. Proteins were electrophoretically transferred to nitrocellulose filters, probed (IB) with an anti-pospho-STAT5 antibody, and reprobed with an anti-STAT5 antibody (lower panel). B) p21SIE2 complex formation (upper panel). Nuclear extracts were prepared from unstimulated, TGFβ-and AGEstimulated MC. p21SIE2 oligonucleotides were used. p21SIE2 complexes contain STAT5 (lower panel). Nuclear extracts from TGFβ-and AGE-stimulated MC were incubated with an anti-STAT5 antibody. DNA-protein complexes were resolved by nondenaturing PAGE. The upper arrow indicates the supershifted species. C) Effect of the anti-TGFβ or the anti-RAGE on STAT5 activation. Untreated or AGE-and TGFβ−treated MC, alone or in combination with a neutralizing anti-TGFβ antibody or with the blocking anti-RAGE antibody, were lysed. Cells extracts were IP with an anti-STAT5 antibody and processed as above. Filters were probed (IB) with an anti-pospho-STAT5 antibody and reprobed with an anti-STAT5 antibody (lower panels). D) Effect of anti-TGFβ on p21 waf expression. MC stimulated as indicated with or without a neutralizing anti-TGFβ antibody were lysed and processed as above. Filter was IB with anti-p21 waf antibody and reprobed with an anti-β-actin antibody (lower panel). E) STAT5 activation after HG treatment. MC unstimulated or stimulated with HG or with HM were lysed and IP with an anti-STAT5 antibody. Proteins were processed as above and filter was probed (IB) with an anti-pospho-STAT5 antibody and reprobed with an anti-STAT5 antibody (lower panels). STAT5 activation and p21 waf expression in the experiments were also quantified by densitometric analysis as described in Methods (upper panels). F) Effect of anti-TGFβ or anti-RAGE on collagen production. MC stimulated with and without an anti-TGFβ antibody or with the blocking anti-RAGE antibody were assayed for collagen production as described in Methods. Four different experiment were performed with similar results. *P < 0.05, control vs. experimental groups; §P < 0.05, AGE vs AGE plus anti-TGFβ, AGE vs. AGE plus anti-RAGE; TGFβ vs. TGFβ plus anti-TGFβ; HG vs. HG plus anti-TGFβ and Amadori adducts vs. Amadori adducts plus anti-TGFβ. All experiments were performed at least 4 times, and similar results were obtained. A) Progression in the S-phase. Wild-type and p21−/− fibroblasts were stimulated for 18 h in serum-free medium with AGE (0.6 mg/ml), TGFβ (10 ng/ml), HG, Amadori adducts (0.6 mg/ml), and with 10% FCS as positive control and then fixed with 70% ethanol. After digestion with RNase, DNA was stained with propidium iodide and analyzed by a flow cytometer as described in Methods. * and §P < 0.05 control vs. experimental groups. B) Collagen production. Wild-type and p21−/− fibroblasts were stimulated in serum-free medium, with AGE (0.6 mg/ml), TGFβ (10 ng/ml), NG, HG, or Amadori adducts (0.6 mg/ml) and assayed for collagen production as described in Methods. Five different experiments, each in triplicate, were performed with similar results. * and §P < 0.05 control vs. experimental groups for wild-type or p21−/− fibroblasts, respectively. waf are expressed in diabetic kidney biopsies. Representative sections from healthy subjects (A-C), from micro-albuminuric patients (D-F) and from macro-albuminuric patients (G-I). Sections were double immunostained with an anti-phospho-STAT5 antibody (green) and an anti-p21 waf antibody (red). As secondary antibodies, FITC-and RITC-conjugated anti-IgG, respectively, were used. Ethidium bromide was used to stain nucleus of cells contained inside glomeruli (C, F, I) and to confirm nuclear localization of phospho-STAT5 (yellow staining of phospho-STAT5 positive cells; F and I). Primary antibody was omitted on section used as negative control (data not shown). p-STAT5 and p21 waf positive nuclei correspond to 15% ± 3 in micro-albuminuric diabetic patients and 45% ± 4 in macro-albuminuric diabetic patients. Original magnification x250. 
